CROZER CHESTER MEDICAL CENTER — History
CCN 390180 | 3-year financial timeline | COVID resilience: 14/100
🛡️ Public data only — no PHI permitted on this instance.
$460M
Latest Revenue (FY2022)
-7.3%
Revenue CAGR (3yr)
-19.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $535M | $491M | $460M | -6.3% | -7.3% |
| Operating Expenses | $559M | $532M | $550M | +3.2% | -0.8% |
| Operating Margin | -4.5% | -8.5% | -19.6% | -130.3% | +0.0% |
| Net Income | $-24M | $-42M | $-90M | -115.7% | +0.0% |
| Licensed Beds | 343 | 316 | 296 | -6.3% | -7.1% |
| Total Patient Days | 77,214 | 71,650 | 63,949 | -10.7% | -9.0% |
| Medicare Day % | 25% | 22% | 23% | +1.5% | -5.5% |
| Medicaid Day % | 5% | 5% | 5% | -9.5% | -5.8% |
COVID Impact & Recovery
Resilience Score: 14/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.0% ($535M → $460M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.3%
This Hospital
+7.6%
State Avg
Latest Margin
-19.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $422M | -27.1% |
| FY2024 (proj) | $385M | -34.6% |
| FY2025 (proj) | $347M | -42.1% |